Chicago: Nicotinic AChRs—Mechanistic Basis for New Drug Discovery?
It’s refreshing to hear about studies showing clear convergence between biology, drug action, and behavior, all in the space of a few seconds, no less...
6361 RESULTS
Sort By:
It’s refreshing to hear about studies showing clear convergence between biology, drug action, and behavior, all in the space of a few seconds, no less...
Relationships forged amidst the glitz and glamour of Las Vegas have a reputation for ending badly; the one between the University of Nevada, Reno (UNR), and the Lou Ruvo Brain Institute (LRBI) was apparently no exception...
At a satellite symposium, “Nicotinic Acetylcholine Receptors (nAChRs) as Therapeutic Targets,” clinical discussion of cognitive treatments focused largely on nAChR agonists...
Days before the masses swarmed to the SfN annual meeting, a more intimate assembly of 287 exchanged the latest buzz on nicotinic acetylcholine receptors...
In Alzheimer disease research, focus has recently shifted away from large plaques and toward small oligomers of amyloid as a potential cause of disease...
The window of opportunity for regenerating nerves severed in spinal cord injuries may be more expansive than previously thought...
The long axons of neurons act as intracellular highways, with motor proteins shuttling their cargo up and down microtubule tracks...
St. Louis: Scientists, Families Target Preclinical Detection, Trials St. Louis: The Family View—What Do Study Volunteers Want From DIAN? St. Louis: Cognition Pre-dementia—Like eFAD, Like LOAD? St. Louis: Biomarkers Pre-dementia—Like eFAD, Like LOAD? St. L
DIAN was founded with the hope that its participating families could be offered a prevention trial and/or treatment trial before too long...
At the 7th Leonard Berg Symposium, brain imaging researchers of various stripes took stock of what brain imaging tells the field about the preclinical period of Alzheimer disease...
One question that pervaded the 7th Leonard Berg Symposium is whether dominantly inherited Alzheimer disease really is the same disease as the common late-onset forms...
Researchers have almost completely banished microglia from the brains of APP transgenic mice, and to their surprise they found absolutely no change in plaque size or number...
As throughout this conference, talks toggled between what’s known in LOAD and eFAD, comparing all the while how well knowledge on these forms of AD matches up...
Evidence suggests that diabetes is a risk factor for Alzheimer disease, but how does it affect those who already have AD?...
At the 7th Leonard Berg Symposium scientists and patient advocates came together to exchange the latest news on detecting disease presymptomatically...